AevisBio is a biotech company applying targeted protein modulator (TPM) technology to improve human life

We are committed to addressing medical unmet needs for people suffering from aging and diseases by TPM technology overcoming the current limitations in drug development process.

Target diseases of interest include but are not limited to drug resistant cancers, vascular diseases, immune disorders and neurodegenerative diseases.

We will focus on the development of highly innovative and differentiated medicines by TPM technology to provide not only the clinical benefits but also human welfare.